Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) EBT Margin (2019 - 2023)

Historic EBT Margin for Benitec Biopharma (BNTC) over the last 5 years, with Q2 2023 value amounting to 65114.29%.

  • Benitec Biopharma's EBT Margin changed N/A to 65114.29% in Q2 2023 from the same period last year, while for Mar 2024 it was 307371.43%, marking a year-over-year decrease of 2789831900.0%. This contributed to the annual value of 25485.33% for FY2023, which is 9839600.0% down from last year.
  • According to the latest figures from Q2 2023, Benitec Biopharma's EBT Margin is 65114.29%.
  • Benitec Biopharma's EBT Margin's 5-year high stood at 8220.0% during Q2 2020, with a 5-year trough of 379500.0% in Q1 2021.
  • For the 5-year period, Benitec Biopharma's EBT Margin averaged around 80666.78%, with its median value being 8051.85% (2023).
  • In the last 5 years, Benitec Biopharma's EBT Margin crashed by 2000000000bps in 2021 and then skyrocketed by 2000000000bps in 2022.
  • Benitec Biopharma's EBT Margin (Quarter) stood at 2719.48% in 2019, then plummeted by -11891bps to 326100.0% in 2020, then soared by 94bps to 19384.0% in 2021, then plummeted by -107bps to 40135.71% in 2022, then tumbled by -62bps to 65114.29% in 2023.
  • Its EBT Margin stands at 65114.29% for Q2 2023, versus 8051.85% for Q1 2023 and 40135.71% for Q4 2022.